All Updates

All Updates

icon
Filter
Funding
Phospholutions secures USD 10.15 million investment to commercialize solution
Natural Fertilizers
Aug 10, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Natural Fertilizers

Natural Fertilizers

Aug 10, 2023

Phospholutions secures USD 10.15 million investment to commercialize solution

Funding

  • Phospholutions, a Pennsylvania-based fertilizer technology company for agricultural and turf applications, has received a USD 10.15 million investment led by Advantage Capital. Existing investors Conti Ventures, Tekfen Ventures, Maumee Ventures, and Ben Franklin Technology Partners, alongside new investor Keytrade, also joined the round.

  • The company expects to use the funds for the commercialization of its RhizoSorb fertilizer additive in the US row crop market. 

  • The company also noted that it plans to expand field trials of RhizoSorb to China, Brazil, and Canada in the 2024 growing season, following successful trials in five countries outside the US, including India, New Zealand, and Turkey.

  • Analyst QuickTake: Phospholutions is securing necessary capital to bring its solution to-market successfully. In July 2022, Phospholutions raised an undisclosed amount of capital to support its commercialization efforts. Prior to that, the company raised USD 10.3 million in Series A funding in January 2021, which enabled the company to trial its products in new markets. Phospholutions also secured USD 250,000 in March 2022 as the runner-up in UPL's Radicle Carbon & Soil Challenge for its development of an environmentally friendly fertilizer additive. As of date, the company has raised USD 32.5 million in funding. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.